GLP-1s will disrupt the economy in 2025, FDA declares the tirzepatide shortage over, Novo Nordisk stock plummets, and much more.
The Gut Punch Weekly #1
GLP-1s will disrupt the economy in 2025, FDA declares the tirzepatide shortage over, Novo Nordisk stock plummets, and much more.